In this free webinar, see how formulation decisions directly impact Critical Quality Attributes. Attendees will learn how comprehensive analytical data informs robust control strategy development. The ...

Formulation is arguably the most critical—and challenging—component of biopharmaceutical drug development, second only to the molecule itself. Formulation’s far-reaching consequences help sponsors ...

CRDMOs offer a continuum of services from early discovery to clinical manufacturing, addressing solubility and stability challenges in NCE development. Advanced technologies like spray drying and ...

The authors describe a method-validation-by-design (MVbD) approach to validate a method over a range of formulations using both design-of-experiment and quality-by-design principles to define a design ...

ALBANY, New York, Jan. 19, 2015 /PRNewswire/ -- AMRI (AMRI) today announced it received a 10-year federal contract award from the National Institutes of Health (NIH) for drug development and ...

Advanced analytical services support partners from product characterization and assay development to GMP readiness and clinical manufacturingIntravacc offers state-of-the-art analytical methods for ...

MONTREAL, MAY 14, 2013 — /PRNewswire/ -- Halo Pharma today announced that it has taken a minority ownership position in, and established a formal collaboration with, the drug formulation and ...

Nitrosamines are a class of compounds that can form when amines react with nitrosating agents under favorable conditions.

This article has been disseminated on behalf of Onco-Innovations Limited and may include paid advertising. Onco-Innovations (CBOE CA: ONCO) (OTCQB: ONNVF) announced a services agreement with Nanosoft ...

The pharmaceutical development of a cardiovascular polypill presents several unique challenges. The selection of the type and number of active drugs to be incorporated requires important consideration ...